Nextech Invest’s Revolution Medicines RVMD Stock Holding History

Nextech Invest’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$739M	Hold	7,601,087	–	–	52.02%	1
2025 Q4	$605M	Hold	7,601,087	–	–	58.53%	1
2025 Q3	$355M	Hold	7,601,087	–	–	54.03%	1
2025 Q2	$280M	Hold	7,601,087	–	–	52.92%	1
2025 Q1	$269M	Hold	7,601,087	–	–	62.46%	1
2024 Q4	$332M	Buy	7,601,087 +1,304,347	+21%	+$65.8M	53.94%	1
2024 Q3	$286M	Hold	6,296,740	–	–	40.09%	1
2024 Q2	$244M	Hold	6,296,740	–	–	41.11%	1
2024 Q1	$203M	Hold	6,296,740	–	–	32.17%	1
2023 Q4	$181M	Buy	6,296,740 +1,457,211	+30%	+$35M	33.64%	1
2023 Q3	$134M	Hold	4,839,529	–	–	40.59%	1
2023 Q2	$129M	Hold	4,839,529	–	–	44%	1
2023 Q1	$105M	Buy	4,839,529 +650,000	+16%	+$16M	43.76%	1
2022 Q4	$99.8M	Hold	4,189,529	–	–	39.7%	1
2022 Q3	$82.6M	Buy	4,189,529 +250,000	+6%	+$5.49M	26.68%	1
2022 Q2	$76.8M	Hold	3,939,529	–	–	25.9%	1
2022 Q1	$100M	Buy	3,939,529 +971,315	+33%	+$21.1M	28.69%	1
2021 Q4	$74.7M	Buy	+2,968,214	New	+$83.7M	19.68%	2

Other funds holding RVMD

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Nextech Invest's RVMD Position: Q1 2026 in Review

Nextech Invest held its Revolution Medicines (RVMD) position steady in Q1 2026 at 7,601,087 shares worth $739M. The position accounts for 52.02% of the portfolio, ranked #1.

Nextech Invest first reported a position in RVMD in Q4 2021 and has held it in 18 quarters since. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

Nextech Invest held 7,601,087 shares of Revolution Medicines worth $739M as of Q1 2026.
Nextech Invest left its Revolution Medicines share count unchanged in Q1 2026.
Revolution Medicines made up 52.02% of Nextech Invest's portfolio in Q1 2026, its #1 holding.
Nextech Invest first reported a position in Revolution Medicines in Q4 2021 and has held it in 18 quarters since.
512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Nextech Invest's 13F filing for Q1 2026, filed 15 May 2026.